Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 11 holding rows worth $286,520,062.

Accession
0001193125-26-053268
Filed
2026-02-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2025

A holdings report, 11 entries on the cover page, a total value of $286,520,062 stated on the cover page (in dollars after the unit check, H1), rows summing to $286,520,063 with VALUE read as dollars as filed, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NUVATION BIO INC COM CL A67080N101Stock8,081,089$72,406,557dollars as filed
BRIDGEBIO ONCOLOGY THERAPEUT107924102COM NEW3,289,661$41,186,556dollars as filed
BETA BIONICS INC08659B102COMMON STOCK1,316,183$40,104,096dollars as filed
BICARA THERAPEUTICS INC055477103COM2,204,650$37,104,260dollars as filed
KESTRA MED TECHNOLOGIES LTDG52441105SHS1,373,591$36,427,633dollars as filed
UPSTREAM BIO INC91678A107COMMON STOCK1,326,293$36,008,855dollars as filed
ENGENE HOLDINGS INC29286M105COM876,357$7,913,504dollars as filed
ALUMIS INC022307102COM653,223$6,375,456dollars as filed
SANA BIOTECHNOLOGY INC799566104COM843,750$3,434,063dollars as filed
IMAGENEBIO INC45175G207CMN455,361$3,141,991dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK248,672$2,417,092dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001193125-26-053268this filing2026-02-17acceptance time not in the bulk data set